ID
16131
Description
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT02338921
Link
https://clinicaltrials.gov/show/NCT02338921
Keywords
Versions (2)
- 6/30/16 6/30/16 -
- 7/1/16 7/1/16 - Julian Varghese
Uploaded on
July 1, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Type 2 Diabetes NCT02338921
Eligibility Type 2 Diabetes NCT02338921
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diabetes Mellitus, Insulin-Dependent | Gestational Diabetes | Secondary diabetes mellitus
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
- UMLS CUI [2]
- C0085207
- UMLS CUI [3]
- C0271640
Description
Medical contraindication sitagliptin | Medical contraindication dapagliflozin | Medical contraindication lobeglitazone
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C1565750
- UMLS CUI [2,1]
- C1301624
- UMLS CUI [2,2]
- C2353951
- UMLS CUI [3,1]
- C1301624
- UMLS CUI [3,2]
- C2744790
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Pharmaceutical Preparations Affecting Glycaemia control | Steroids
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0392760
- UMLS CUI [1,3]
- C3267174
- UMLS CUI [2]
- C0038317
Description
Disease Affecting drug efficacy | Disease Affecting drug safety
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0392760
- UMLS CUI [1,3]
- C0598333
- UMLS CUI [2,1]
- C0009488
- UMLS CUI [2,2]
- C0392760
- UMLS CUI [2,3]
- C0678800
Description
Illness Major | Liver diseases | Kidney Failure | Heart Diseases | Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0221423
- UMLS CUI [1,2]
- C0205164
- UMLS CUI [2]
- C0023895
- UMLS CUI [3]
- C0035078
- UMLS CUI [4]
- C0018799
- UMLS CUI [5]
- C0006826
Description
contraindication Antidiabetics Oral
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0935929
- UMLS CUI [1,3]
- C1527415
Similar models
Eligibility Type 2 Diabetes NCT02338921
- StudyEvent: Eligibility
C0025598 (UMLS CUI [2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0085207 (UMLS CUI [2])
C0271640 (UMLS CUI [3])
C1565750 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C2353951 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C2744790 (UMLS CUI [3,2])
C0006147 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C3267174 (UMLS CUI [1,3])
C0038317 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C0598333 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0678800 (UMLS CUI [2,3])
C0205164 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2])
C0035078 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0006826 (UMLS CUI [5])
C0935929 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,3])